Press

VANCOUVER, B.C.: May 9, 2023 – EMPOWER CLINICS INC (CSE:EPW) (PINK:EPWCF) ("Empower" or the "Company") an integrated healthcare company with a developing research and clinical trials divisions announces various corporate updates. RESEARCH AND CLINICAL TRIALS The Company announced on April 17, 2023 that its subsidiary EPW Curesearch LLC (“EPWC”) has signed an agreement to develop a program for Pharmaceutical Research and Clinical Trials Services (the “Services”) with an established specialist...

Addition Of Seasoned Principal Investigators At First SMO Site Dramatically Expands Access to Securing Multiple Research Projects Covering Numerous Specialties VANCOUVER, B.C.: April 25, 2023 – EMPOWER CLINICS INC (CSE:EPW) (PINK:EPWCF) ("Empower" or the "Company") an integrated healthcare company with a developing research and clinical trials divisions is pleased to announce that its subsidiary EPW Curesearch LLC (“EPWC”) has signed two new Research Services Agreements (“Research Agreement”)...

The launch of PulseIR will deliver a data-driven, digital IR marketing platform to enhance IR communications and investor engagement. VANCOUVER, BC / April 20, 2023 / EMPOWER CLINICS INC (CSE:EPW)(OTC PINK:EPWCF) (“Empower” or the “Company“), an integrated healthcare company – serving patients through medical centers, a medical device company, and with a developing research and clinical trials division – announces that the company is officially launching the PulseIR technology platform, a...